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Cellular senescence entails a stable cell-cycle arrest
and a pro-inflammatory secretory phenotype, which
contributes to aging and age-related diseases.
Obesity is associated with increased senescent cell
burden and neuropsychiatric disorders, including
anxiety and depression. To investigate the role of
senescence in obesity-related neuropsychiatric
dysfunction, we used the INK-ATTAC mouse model,
from which p16Ink4a-expressing senescent cells can
be eliminated, and senolytic drugs dasatinib and
quercetin. We found that obesity results in the accu-
mulation of senescent glial cells in proximity to the
lateral ventricle, a region in which adult neurogenesis
occurs. Furthermore, senescent glial cells exhibit
excessive fat deposits, a phenotype we termed
‘‘accumulation of lipids in senescence.’’ Clearing
senescent cells from high fat-fed or leptin receptor-
deficient obesemice restored neurogenesis and alle-
viated anxiety-related behavior. Our study provides
proof-of-concept evidence that senescent cells are
major contributors to obesity-induced anxiety and
that senolytics are a potential new therapeutic
avenue for treating neuropsychiatric disorders.
INTRODUCTION
Obesity is associated with a range of neurodegenerative and
psychiatric disorders, including depression and anxiety (Gariepy
et al., 2010; Hryhorczuk et al., 2013; Stunkard and Wadden,Cell Metabolism 29, 1–1
This is an open access article under the CC BY-N1992), with the latter being one of the most common behavioral
traits in obese patients (Gariepy et al., 2010). Increased anxiety-
like behavior has been reported in rodents genetically predis-
posed to develop obesity, e.g., db/db mice (Dinel et al., 2011),
and in high-fat diet (HFD)-induced obesity (Heyward et al.,
2012; Mizunoya et al., 2013). Processes such as inflammation
(Capuron and Miller, 2011; Lasselin and Capuron, 2014), altered
hormone signaling (Ulrich-Lai and Ryan, 2014), and stem cell
dysfunction (Anacker and Hen, 2017; Gao et al., 2017) have
been speculated to underlie obesity-related anxiety, but the un-
derlying mechanisms have not been identified. Here, we investi-
gate the hypothesis that anxiety-like behavior in obesity can be
caused by increased senescent cell burden.
Cellular senescence is an irreversible cell-cycle arrest caused
by a range of stresses, including telomere dysfunction (d’Adda di
Fagagna et al., 2003), oxidative stress (Passos et al., 2010),
inflammation (Jurk et al., 2014), intracellular accumulation of
damage (Ogrodnik et al., 2018), and metabolic dysfunction (Wi-
ley and Campisi, 2016). Senescent cells display a variety of
markers, including telomere-associated DNA damage foci
(TAF) (Hewitt et al., 2012), increased activity of lysosomal senes-
cence-associated b-galactosidase (Dimri et al., 1995), chromatin
changes (senescence associated heterochromatin foci, SAHF)
(Narita et al., 2003), and frequently increased expression of the
cyclin-dependent kinase inhibitor proteins, p16Ink4a and p21Cip1.
While cell senescence is a potent tumor suppression mecha-
nism (Mun˜oz-Espı´n and Serrano, 2014), over the long term,
accumulation of senescent cells may impede the regeneration
andmaintenance of renewable tissues and, therefore, contribute
to tissue aging. Additionally, senescent cells secrete a number of
inflammatory cytokines, chemokines, and matrix proteases (the
senescence associated secretory phenotype, SASP) (Coppe´
et al., 2008). The SASP is thought to have evolved as a means
for senescent cells to communicate with the immune system in7, April 2, 2019 ª 2018 The Author(s). Published by Elsevier Inc. 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Obese Mice Exhibit Anxiety-like Behavior that Is Not Directly Related to an Increase in Body Mass
Behavior changes were tested in the open-field (OF) chamber. Dark rectangle marks the central area (25% of total area).
(A) Representative movement traces (red lines) for chow- and high-fat diet (HFD)-fed mice at 10 months of age (baseline).
(legend continued on next page)
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genitor cells to repair tissues (Tchkonia et al., 2013). However,
chronic exposure to the SASP leads to damage to neighboring
healthy cells, thereby contributing to tissue dysfunction during
aging and in age-related diseases (Acosta et al., 2013; Nelson
et al., 2012; Xu et al., 2018).
Accumulation of senescent cells has been observed during
obesity (Minamino et al., 2009; Ogrodnik et al., 2017; Schafer
et al., 2016), during aging (Baker et al., 2016; Jurk et al., 2012;
Wang et al., 2009; Xu et al., 2015; Yousefzadeh et al., 2018),
and at the sites of pathogenesis in multiple chronic and age-
related diseases (Tchkonia et al., 2013). Clearance of senescent
cells can delay, prevent, or alleviate multiple age-related disor-
ders (Kirkland and Tchkonia, 2017; Xu et al., 2018). These include
age-related cardiac and vascular dysfunction (Childs et al., 2016;
Roos et al., 2016), frailty (Baar et al., 2017; Baker et al., 2016; Xu
et al., 2018; Zhu et al., 2015), hepatic steatosis (Ogrodnik et al.,
2017), liver fibrosis (Moncsek et al., 2018), osteoporosis (Farr
et al., 2017), osteoarthritis (Jeon et al., 2017), and pulmonary
fibrosis (Schafer et al., 2016), among others. In the context of
the brain, recent reports have shown that removing senescent
cells improves phenotypes in mouse models of Parkinson’s dis-
ease (Chinta et al., 2018) and tau-dependent neurodegenerative
diseases (Musi et al., 2018; Bussian et al., 2018). However, the
relationship between senescence and neuropsychiatric disor-
ders such as anxiety has not been investigated thus far.
Here, we demonstrate that in obesity, glial cells show
increased markers of cellular senescence in the periventricular
region of the lateral ventricle (LV), a region in close proximity to
the neurogenic niche. Senescent glial cells in obese mice show
excessive fat accumulation, a phenotype we termed ‘‘accumula-
tion of lipids in senescence’’ (ALISE). Importantly, we show that
clearance of senescent cells alleviates the obesity-related
impairment in adult neurogenesis and decreases obesity-
induced anxiety-like behavior. Our work suggests that targeting
senescent cells may represent a new therapeutic avenue for
treating obesity-induced neuropsychiatric dysfunction.
RESULTS
Obese Mice Show Increased Anxiety-like Behavior Not
Related to Body Mass
In order to investigate the relationship between obesity and anx-
iety, 8-month-old C57Bl/6 mice were fed an HFD (60% of calo-
ries from fat) or standard chow diet for 2 months. As expected,
we found that body weight and body fat content were increased
in HFD mice in comparison to chow-fed controls (Figures S1A(B and C) Parameters recorded and analyzed in OF: (B) distance traveled in the cen
entries into the central area (U = 187, p = 0.0006).
(D and E) No significant correlations (linear regression) were found in either cho
traveled in the central area (r = 0.1024, p = 0.5972; r =0.283, p = 0.1704) and (E)
p = 0.1933).
(F) Representative heatmaps of timemice spent in the elevated plusmaze (EPM) fo
(G and H) (G) The frequency of head pokes into open arms (t(36.66) = 2.045; p = 0.04
are significantly decreased in HFD mice when compared to chow-fed mice.
(I and J) No substantial correlations were found between body mass and EPM test
(r =0.09171, p = 0.6361; r =0.1927, p = 0.356) and (J) time spent in open arms (
per group. Mean ± SEM plotted. *p% 0.05 and **p% 0.001.and S1B). To measure anxiety-like behavior, we first employed
the open-field (OF) test. This test evaluates the tendency of
mice to remain close to the walls and avoid open spaces (central
zone), a phenomenon known as thigmotaxis, which is widely
used as an indication of anxiety-like behavior (Simon et al.,
1994). HFD-fed mice were less inclined to explore the central
area of the OF test chamber than the peripheral zone (Figures
1A–1C and S1D), and likewise the total distance covered was
significantly decreased in HFD animals during the test (Fig-
ure S1C). To account for decreased activity in obese animals,
anxiety measurements were analyzed as a function of the total
distance traveled during experimental testing (Figures 1B and
1D). As it has been shown that obesity impacts activity and
exploratory behavior and contributes to anxiety-like behavior
(Friend et al., 2017; Guillemot-Legris and Muccioli, 2017), we
next investigated if body weight and body composition alone
could explain the observed anxiety-like behavior. Linear regres-
sion analysis revealed no significant correlation between body
weight or percentage of fat mass with anxiety-like behavior in
HFD-fed mice (Figures 1D, 1E, and S1E–SIJ). This indicates
that while weight gain is associated with the onset of anxiety-
like behavior, once a certain weight is reached, no correlation be-
tween weight and anxiety is found, which suggests that factors
apart from weight gain must play a role.
As an additional measurement of anxiety-like behavior, we
used the elevated plus maze (EPM) test. The EPM is based on
the animals’ natural fear of heights and open spaces. Increased
anxiety-like behavior in the EPM test is manifested as a decrease
in the number of head-pokes and entries into the open arms. We
found that animals on the HFD had decreased entries into the
open arms of the EPM (frequency and time) compared to lean
animals (Figures 1F–1H), which is indicative of increased anxi-
ety-like behavior. Similar to the OF test, there were no significant
correlations between body and fat mass and anxiety parameters
in either lean or HFD-fed animals (Figures 1I, 1J, S1K, and S1L).
Pharmacogenetic and Pharmacologic Clearance of
Senescent Cells Alleviates Obesity-Related Behavioral
Changes
Several recent reports have demonstrated that the removal of
senescent cells can alleviate a large array of age-related disor-
ders (Kirkland and Tchkonia, 2017). Obesity has been associated
with the accumulation of senescent cells in fat tissue (Minamino
et al., 2009; Schafer et al., 2016; Tchkonia et al., 2010) and
the liver (Ogrodnik et al., 2017). However, a link between
obesity-induced senescence and anxiety has not been investi-
gated. Therefore, we investigated whether senescent cells maytral area (as a function of total distance traveled) (t(54) = 2.359; p = 0.022) and (C)
w or HFD animals between (D) body mass and the normalized distance mice
the number of entries into the central area (r = 0.09993, p = 0.606; r =0.2692,
r chow andHFDmice. Closed arms of themaze are indicated by pink brackets.
8) and (H) the timemice spent with their head in open arms (U = 230, p = 0.0209)
parameters in chow and HFDmice: (I) frequency of head pokes into open arms
r = 0.1477, p = 0.4444; r =0.000444, p = 0.9983). Data are from n = 25–30mice
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Figure 2. Pharmacogenetic and Pharmacologic Clearance of Senescent Cells from Obese Mice Alleviates Obesity-Related Behavioral
Changes
(A) Eight-month-old C57Bl/6(INK-ATTAC) malemicewere split into four groups and assigned to chow (n = 24) or high fat (HF, n = 30) diets and treated at 10months of
age with vehicle (n = 12 for chow and n = 15 for HF) or AP20187 (n = 12 for chow and n = 15 for HF) until 13 months of age.
(B–D) (B) Open-field (OF) testing: representative movement traces (red lines) of lean and obese INK-ATTACmice treated with/without AP20187 (AP) indicates that
anxiety-like behavior of HFDmice can be alleviated by AP treatment asmeasured by (C) the normalized distance traveled in the central area of the OF box (U = 36,
p = 0.0037; U = 64, p = 0.0453) and (D) increased frequency of entries into the central area. Alleviation of anxiety-like behavior of HFD mice was also observed in
the EPM test (U = 10.5, p < 0.0001; U = 64.5, p = 0.0463).
(E) Representative heatmap images of the time mice spent in open and closed sections of the EPM. Parameters were registered by EthoVision software.
(F andG) (F) Frequency of head pokes into the open arms (U = 17.5, p < 0.0001; t(27) = 2.1; p = 0.0452) and the (G) timemice spent with their heads in the open area
were significantly reduced with HFD and increased with AP (U = 26, p = 0.001; U = 59.5, p = 0.0472).
(H) Representative movement traces (red lines) of db/db and heterozygous control mice with or without treatment with senolytic cocktail, dasatinib + quercetin
(D+Q) in the OF test during a 30-min trial.
(I and J) Data indicate an improvement in the anxiety-like behavior of db/dbmice upon D+Q treatment determined by OF test parameters: (I) normalized distance
traveled in the middle area (t(7.259) = 2.269, p = 0.0562; t(21) = 3.001, p = 0.0068) and (J) frequency of entries into the middle area of the OF box (U = 1, p < 0.0001;
U = 24.5, p = 0.009).
(K and L) In the OF test, INK-ATTAC;db/db mice (K) displayed a significant difference in the distance traveled in the central area after treatment with AP20187
compared to vehicle (U = 61; p = 0.0106), but (L) the number of entries into the central area was not significantly increased after treatment with AP (U = 85.5;
p = 0.1096).
Data are from n = 12–15 mice per group for (A)–(G); n = 8–12 mice per group for (H)–(J); n = 5–9 mice per group for (K)–(L). Mean ± SEM plotted. *p% 0.05 and
**p% 0.001.
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INK-ATTAC mouse model. This model allows the selective sui-
cide gene-mediated ablation of highly p16Ink4a-expressing cells,
many of which are senescent, upon administration of the drug
AP20187 (AP), which cross-links the ATTAC fusion protein,
thereby activating its caspase 8 moiety to induce apoptosis
(Baker et al., 2011; Xu et al., 2015).
We repeatedly treated chow- andHFD-fed 10-month-oldmice
with AP or vehicle (Figure 2A) over the duration of 10 weeks,
which resulted in no significant changes in body weight (Fig-
ure S2A) or body composition (data not shown). Tomeasure anx-
iety-like behavior, we first used the OF test and confirmed our
previous observation that animals on the HFD were less inclined
to explore the center of the open field chamber than the periph-4 Cell Metabolism 29, 1–17, April 2, 2019ery, asmeasured by the distance traveled (Figure 2C) and entries
(Figure 2D) into the central zone. Furthermore, HFD-fed mice
traveled significantly less throughout the duration of the tests,
covering a smaller total distance (Figure S2C). To take this into
account, most measured parameters (as indicated) were ex-
pressed as a function of the total distance traveled. Clearance
of p16Ink4a-positive cells with AP reduced HFD-induced anxi-
ety-like behavior as measured by distance covered in the central
zone (Figures 2B and S2B) and entries into the central zone (Fig-
ure 2C). However, AP treatment did not affect the total distance
traveled (Figure S2C) or any of the aforementioned parameters in
the chow-fed mice (Figures 2B–2D and S2C).
Next, we assessed anxiety-like behavior with the EPM. As pre-
viously noted, obese animals avoided entries into the open arms
Please cite this article in press as: Ogrodnik et al., Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis, Cell Metabolism
(2018), https://doi.org/10.1016/j.cmet.2018.12.008of the EPM (showing lower frequency of entries and less time
spent) compared to lean animals (Figures 2E–2G, S2D, and
S2E), indicating increased anxiety-like behavior. Consistent
with the data from the OF test, AP treatment significantly
decreased the anxiety-like phenotype in obese animals as indi-
cated by the frequency of head entries into the open arms of
the EPM (Figures 2E–2G, S2D, and S2E). Other cognitive func-
tions, such as short-term memory (Figures S2F and S2G)
measured by the Stone’s maze test, were not altered by the
HFD or AP treatment. Altogether, these results show that
specific elimination of p16Ink4a+-senescent cells from obese
INK-ATTAC mice alleviates anxiety-like behavior but has no ef-
fect on memory performance.
To exclude off-target effects of the drug AP, wild-type C57Bl/6
mice were treated with the drug and tested for anxiety-like
behavior. Consistent with previous studies, wild-type mice
showed a significant difference between chow and HFD in the
OF test before the start of the treatment (Figure S2H), but no dif-
ference was observed in the HFD-fed mice after treatment with
AP (Figure S2I).
In addition to the HFD-fed mice, we conducted complemen-
tary experiments in db/db mice in which obesity is caused by a
point mutation in the leptin receptor gene lepr, leading to spon-
taneous type 2 diabetes (Wang et al., 2014). We treated these
mice intermittently for 2 months with the senolytic drug cocktail,
Dasatinib and Quercetin (D+Q) (Zhu et al., 2015). db/db mice
have significantly increased body weights and adipose depot
weights when compared to lean db+/ heterozygous littermates,
but interestingly, body weight did not change over the course of
D+Q treatment (Figures S2J and S2K).
Similar to HFD-fed mice, db/db mice exhibited increased
anxiety-like behavior as assessed by the OF test (Figures 2H–
2J). We observed that the total distance covered (Figure 2I)
and the number of entries (Figure 2J) into the central zone
were reduced in db/db mice compared to their non-obese,
db+/ heterozygous littermates, a phenotype which could be
significantly alleviated by treatment with D+Q. While obese
db/db mice covered a shorter total distance in comparison to
their lean littermates, D+Q treatment did not change the total
distance covered in the db/db or db/db+/ mice (Figures S2K
and S2L).
Finally, we confirmed these results in a cohort of double-
transgenic, INK-ATTAC;db/db mice. Similarly to the treatment
with D+Q, genetic clearance of p16Ink4a-positive senescent
cells in INK-ATTAC;db/db mice did not alter body weight,
body composition, or activity (Figures S2M–S2O). Importantly,
clearance of p16Ink4a-positive senescent cells in INK-ATTAC;
db/db mice reduced anxiety-like behavior as assayed by the
OF test (Figures 2K and 2L). To exclude off-target effects of
the drug AP, db/db mice were treated with AP and no off-target
effects on anxiety-like behavior were observed in OF testing
(Figure S2P). Similar to our previous observations, linear
regression analysis showed no significant correlations between
body weight and anxiety-like behavior in HFD-fed INK-ATTAC
(with and without AP) or db/db (with or without AP or D+Q)
mice (Figures S2Q–S2S).
In conclusion, our data show that pharmacological or pharma-
cogenetic clearance of senescent cells in two different models of
obesity significantly alleviates anxiety-like behavior.Pharmacological and Pharmacogenetic Senolytic
Approaches Reduce Senescent Cell Burden and
Alleviate Systemic Inflammation
To investigate the effectiveness of senescent cell clearance in
HFDmice, wemeasured senescencemarkers in the perigonadal
adipose tissue, a tissue previously shown to exhibit a marked in-
crease in the number of senescent cells with age (Schafer et al.,
2016; Tchkonia et al., 2010; Xu et al., 2015).
We found that the senescence markers SA-b-Gal, p16, and
TAF were increased in INK-ATTACmice on HFD and were signif-
icantly reduced upon administration of AP (Figures 3A–3C). p21
and g-H2A.X were increased in HFD animals but were not signif-
icantly changed after AP treatment (Figures S3A and S3B). Simi-
larly, we found that db/db mice had an increased burden of
senescent cells in perigonadal fat (measured by SA-b-Gal and
TAF frequency) compared to db/db+/ mice. This was signifi-
cantly reduced by treatment with the senolytic cocktail, D+Q
(Figures 3D–3F).
Given that the senolytic approaches we applied act systemi-
cally, it is possible that they reduce pro-inflammatory SASP fac-
tors that can penetrate the blood-brain barrier and therefore
impact the brain. To investigate this possibility, we analyzed
blood plasma for a large array of SASP factors. Evaluation of
circulating cytokines in the bloodstream of chow- and HFD-fed
INK-ATTACmice revealed that HFD resulted in the up-regulation
of known SASP factors such as G-Csf, Il-1a and Il-1b, Kc/Cxcl1,
Mcp-1, Mig, and Tnf-a, which were then downregulated upon AP
treatment (Figure 3G). Similarly, SASP factors in the blood
plasma of db/db mice were increased in comparison to lean
db/db+/ littermates and reduced after treatment with D+Q (Fig-
ure 3H). As peripherally derived cytokines have been shown to
inhibit neurogenesis and to drive anxiety and depression
(Anacker and Hen, 2017; Gao et al., 2017; Li et al., 2014), we
correlated the expression of cytokines in the bloodstream with
parameters of anxiety-like behavior measured by OF testing.
We observed significant negative correlations between the
plasma levels of Cxcl1, G-Csf, and Mig and different anxiety-
like measurements in AP-treated HFD mice (Figures 3I–3K and
S3C) and D+Q-treated db/db mice (Figures S3D and S3E),
whereas no correlation was found for Tnf-a, Il-6, andMcp-1 (Fig-
ures S3F–S3H). These results led us to further investigate the
impact of systemic factors on the observed anxiety phenotype.
As Cxcl1 is the cytokine that best correlates with anxiety-like
behavior and has been previously associated with obesity (Nu-
nemaker et al., 2014), we injected lean animals with recombinant
murine Cxcl1. As expected, injection of Cxcl1 led to increased
levels of circulating Cxcl1 (Figure S3I). Additionally, increased
plasma Cxcl1 resulted in a slight decrease in body weight but
did not alter body composition (Figures S3J and S3K). Examina-
tion of anxiety-like behavior using the OF (Figure S3L) and EPM
(Figure S3M) tests showed no difference between treated and
non-treated animals. To further examine the role of Cxcl1 in anx-
iety-like behavior, we treated HFD mice with reparixin, which in-
hibits the Cxcl1 receptors Cxcr1 and Cxcr2. Mice on reparixin
had a small increase in body weight (Figure S3N), but no differ-
ence in body fat (Figure S3O), in comparison to non-treated
mice. Again, we observed no difference in behavior between
the treated and non-treated groups when animals were tested
in theOF box (Figure S3P) or the EPM (Figure S3Q). These resultsCell Metabolism 29, 1–17, April 2, 2019 5
Figure 3. Clearance of Senescent Cells from Obese Animals Reduces Circulating Cytokine Levels
(A) Quantification of percentage of senescence-associated beta-galactosidase (SA-b-Gal)-positive cells in perigonadal adipose tissue shows increased values in
HFD-fed animals and complete rescue after treatment with AP20187 (t(11) = 5.563, p = 0.0002; t(12) = 5.739, p < 0.0001).
(B and C) Senescence markers (B) p16 (measured by RT-PCR) (U = 5, p = 0.0221; t(13) = 2.631, p = 0.0208) and (C) telomere associated DNA damage foci (TAF)
(t(11) = 9.495, p < 0.0001; t(13) = 2.913, p = 0.0121) show a similar pattern.
(D and E) (D) Representative images and (E) quantification of SA-b-Gal activity in perigonadal adipose tissue of db/db and db/+mice shows that the percentage
of SA-b-Gal-positive cells increases in db/db mice compared to db/+ and is significantly reduced after treatment with the senolytic cocktail, D+Q (t(17) = 5.615,
p < 0.0001; t(21) = 2.504, p = 0.0206).
(F) Frequencies of TAF-positive cells in perigonadal adipose tissue of db/db mice increased significantly in comparison to db/+ mice and decreased after D+Q
treatment (t(16) = 2.612, p = 0.0189; t(21) = 5.937, p < 0.0001).
(G) Cytokine protein expression [fold change] in blood plasma from HFD animals treated with/without AP20187.
(H) Cytokine expression [fold change] in blood plasma from db/db animals treated with/without AP20187.
(legend continued on next page)
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(2018), https://doi.org/10.1016/j.cmet.2018.12.008suggest that Cxcl1 alone is not sufficient to induce an anxiety-
like phenotype; however, they do not exclude the possibility
that other soluble SASP factors are involved in the process.
Recently, it has been shown that transplantation of relatively
low numbers of senescent cells in young animals resulted in
physical dysfunction measured by Rotarod performance, grip
strength, or endurance compared to the transplantation of
non-senescent cells (Xu et al., 2018). Importantly, this study
showed that the transplantation of senescent cells resulted in
long-lasting systemic effects in tissues located distantly from
where senescent cells were injected.
To test the hypothesis that senescent cells can induce anxiety-
like behavior via systemic effects, we transplanted senescent
or non-senescent cells into lean mice and assessed behavior
and physical function 6 and 12 weeks later (Figure S3R). We
confirmed our previous observations that transplanted senes-
cent cells reduced physical function (Xu et al., 2018), as
measured by Rotarod (Figure S3S), but had no effect on anxi-
ety-like behavior using the OF test (Figures S3T–S3W). Together,
these experiments suggest that presence of senescent cells
elsewhere in the body is not sufficient to induce an anxiety-like
phenotype in mice.
Senolytic Treatment Reduces the Frequency of
Senescent Cells in the Amygdala andHypothalamus, but
Not in Other Regions of the Brain
Our previous results led us to hypothesize that obesity could
induce senescence specifically in the brain, thereby contributing
to an anxiety-like phenotype. Given the reported occurrence of
senescence markers in neurons and glial cells of aging mice in
the cortex, cerebellum, and hippocampus (Jurk et al., 2012;
Kang et al., 2015), we first assessed markers of senescence in
these regions of the brains of obese and lean INK-ATTAC mice
treated with and without AP. We found no differences in the se-
nescent markers p21, p16, gH2A.X, or TAF among any of the
experimental groups (Figures S4A–S4D). This is consistent with
the absence of differences in memory and learning among any
of the experimental groups as assessed by Stone’s maze (Fig-
ures S2F and S2G).
Interestingly, assessment of senescent cells in the amygdala,
a region of brain associated with emotional responses such as
anxiety and fear (Adhikari et al., 2015), revealed a significant in-
crease in the number of p16Ink4a-positive cells in HFD-fed mice
(Figure 4A). TAF-positive neurons in the basomedial layer of
the amygdala were significantly increased in HFD mice and
significantly decreased by treatment with AP (Figures 4B–4D).
Next, we analyzed the burden of senescent cells in the hypothal-
amus close to the 3rd ventricle and found that NeuNneg (Figures
4E and 4F) and NeuNpos (Figures S4E and S4F) senescent cells
were significantly increased in HFD compared to lean mice
and were significantly decreased by treatment of HFD-fed
mice with AP.
Together, these data indicate that HFD does not induce
senescence in regions of the brain implicated in learning, mem-(I–K) Linear regression analysis between anxietymarkers and cytokines in blood p
p = 0.0188), (J) G-Csf (r = 0.3507, p = 0.079), (K) Mig (r = 0.4205, p = 0.0325)
Data are from n = 6–9 mice per group for (A)–(C) and (G); n = 7–12 mice per group
0.05 and **p% 0.001.ory, or motor neuron control such as the cortex, cerebellum, and
hippocampus. However, HFD induces senescence in the hypo-
thalamus and amygdala, which may contribute to its effects on
anxiety-like behavior, and treatment with AP reduced senescent
cell abundance and attenuated these behavioral changes.
Clearance of Senescent Cells Decreases
Periventricular Accumulation of Lipid-Laden Glia in
Obese Animals
Senescent cells have been shown to accumulate in obesity (Min-
amino et al., 2009; Ogrodnik et al., 2017; Schafer et al., 2016;
Tchkonia et al., 2010), and their prevalence has been related to
the accumulation of ectopic fat (Ogrodnik et al., 2017). Recently,
it has been reported that cells accumulating lipid droplets in the
brain occur in close proximity to the ventricles, and the number
of these cells increases in mice with age (Shimabukuro et al.,
2016), in Alzheimer’s disease (AD) patients, and in mouse
models of AD (Hamilton et al., 2015). These data led us to inves-
tigate the connection between senescence and fat accumulation
in the brain.
Analysis of perilipin 2 (Plin2) expression (a protein that sur-
rounds lipid droplets) in the brain of HFD-fedmice revealed a sig-
nificant increase in Plin2+ cells (Figure S5A) located in close
proximity to the LV compared to chow-fed controls (Figures 5A
and 5B). Plin2+ cells were also detected around the 3rd and 4th
ventricles and in the periaqueductal gray (PAG) matter (Fig-
ure S5B), but not in other brain regions (data not shown).
Double-staining for Plin2 and the cell-type-specific markers,
vimentin (Vim), Iba1, and NeuN, indicated that Plin2+ cells
are mostly astrocytes (41%) and microglia (19%) (Figures 5C
and 5D).
To investigate whether Plin2+ cells have features of senes-
cence, we analyzed the senescence marker TAF in combination
with immunostaining of Plin2. We found higher frequencies of
TAF in Plin2+ cells (Figure 5E), while the total DNA damage did
not change (Figure S5C). Together, our findings indicate that a
HFD contributes to increased numbers of senescent cells in
the periventricular region of the brain and that these cells prefer-
entially accumulate fat. Given that we previously observed a
similar phenomenon in senescent hepatocytes and fibroblasts
(Ogrodnik et al., 2017), we termed this phenotype ‘‘accumulation
of lipids in senescence’’ (ALISE).
To further investigate the impact of senescent cells on the
buildup of fat in the brain, we used the INK-ATTACmouse model
(Baker et al., 2011). Treatment of HFD-fed INK-ATTAC mice with
AP resulted in a significant reduction of Plin2+ cells (Figures 5F
and 5G), aswell as cells bearing senescencemarkers (Figure 5H).
Furthermore, we analyzed the area occupied by lipid droplets in
ependymal cells and the senescence marker TAF in glia in close
proximity to the LV of db/db animals. We found that these were
significantly increased in db/db in comparison to db/db/+ ani-
mals and significantly reduced after treatment with the senolytic
cocktail, D+Q (Figures S5D–S5F). Additionally, we assessed
neuroinflammation by conducting RNA in situ hybridizationlasma showed a significant negative correlation between (I) Cxcl-1 (r =0.4663,
, and the distance traveled in the central zone of the OF box in HFD-fed mice.
for (E), (F), and (H); n = 27 mice per group for (I)–(K). Mean ± SEM plotted. *p%
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Figure 4. Markers of Senescence in the Amygdala Are Reduced after Treatment with AP20187
(A) p16-positive cells were measured by RNA-ISH in the basomedial layer of the amygdala (t(9) = 2.627, p = 0.0275; t(12) = 2.918, p = 0.0129).
(B) Representative images showing telomere-associated DNA damage foci (TAF), (blue = DAPI, red = telomeres, green = g-H2A.X, white arrow indicates TAF;
scale bars, 5 mm) in 3-mm-thick paraffin embedded brain sections.
(C and D) (C) Mean number of TAF (t(9) = 2.221, p = 0.0535; t(12) = 2.874, p = 0.014) and (D) percentage of NeuN
pos cells with 2 or more TAF (t(4.298) = 3.943,
p = 0.0147; t(11) = 3.854, p = 0.0027) was increased in HFD INK-ATTACmice and was significantly reduced after AP20187 treatment in the basomedial layer of the
amygdala.
(E and F) (E) Mean number of TAF (t(11) = 4.449, p = 0.001; U = 2, p=0.0062) and (F) percentage of NeuN
neg cells with 2 or more TAF (t(11) = 4.501, p = 0.0009; U = 1,
p = 0.0031) were increased in HFD INK-ATTACmice and significantly reduced after AP20187 treatment in the hypothalamus in close proximity to the 3rd ventricle.
Data are from n = 5–6 mice per group for (B)–(D); Mean ± SEM plotted. *p% 0.05 and **p% 0.001.
Please cite this article in press as: Ogrodnik et al., Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis, Cell Metabolism
(2018), https://doi.org/10.1016/j.cmet.2018.12.008against the SASP factors Cxcl1 and Il-6 in combination with
immunostaining for Plin2 in close proximity to the LV of HFD
mice (Figure 5I). Interestingly, we found that more than 80% of
Plin2+ cells were also positive for Cxcl1 and Il-6 (Figures 5J
and 5K).
Finally, anxiety markers in HFD animals, such as distance trav-
eled in the central zone and entries into the central zone, were
strongly negatively correlated with the abundance of Plin2+ cells
in close proximity to the LV (Figures 5L and 5M). Together, these
data support a causal link between the accumulation of lipid-
laden senescent glial cells in obese animals and anxiety-like
behavior.
Suppression of the ALISE Phenotype Reduces
Accumulation of Cytosolic Chromatin Fragments and
the SASP
To further investigate the impact of fat accumulation on cell
senescence, we used mouse adult fibroblasts (MAFs) and
induced senescence by X-ray irradiation as previously
described (Jurk et al., 2014; Ogrodnik et al., 2017). We cultured
senescent cells in the presence or absence of external sources
of lipids (normal FBS versus lipid-deprived FBS). We found that
in the absence of extracellular lipids, cells displaying the ALISE8 Cell Metabolism 29, 1–17, April 2, 2019phenotype (assessed by lipophilic dye, Nile Red) were
decreased (Figures 6A and 6B). Next, we investigated the
impact of fat buildup on different markers of cellular senes-
cence (Figures 6C–6K and S6A). Recently, it has been reported
that senescent cells contain cytoplasmic chromatin fragments
(CCFs) (Ivanov et al., 2013), which activate the DNA-sensing
cGAS-STING pathway, a major driver of the SASP (Dou et al.,
2017). Interestingly, we found that abrogation of the ALISE
phenotype significantly reduced CCF in senescent cells (Fig-
ures 6C and 6D), but not the average number of DNA damage
foci (Figures 6E and 6F) or bi-nuclearity (Figure S6A). Consis-
tent with the hypothesis that enhanced lipid deposition impacts
CCF and the SASP, we found that depriving cells of lipids re-
sulted in a drastic reduction of several key components of
the SASP, such as Il-6, Kc (Cxcl-1), Ip-10 (Cxcl-10), and Lix
(Cxcl-5) (Figures 6G–6K). To investigate if these findings were
restricted to MAFs, we conducted similar experiments in pri-
mary mouse astrocytes. Similar to MAFs, we found an
increased buildup of fat, increased TAF, and higher numbers
of CCF in senescent astrocytes (Figures 6L–6O).
Based on these data, we propose that excessive ALISE may
be a contributor of genomic instability, resulting in the release
of chromatin fragments and activation of the SASP.
Figure 5. Obesity-Related Accumulation of Lipid Droplets in Senescent Periventricular Glia Is Reduced upon Senescent Cell Clearance
(A) Representative images of perilipin 2 (Plin2) staining showing accumulation of cells exhibiting a buildup of lipid droplets in close proximity to the lateral ventricle
(LV) of middle-aged, obese mice compared to their lean littermates. Scale bars, 200 mm/50 mm (for magn.)
(B) Quantification of frequencies of Plin2+ cells in the proximity (up to 250 mm from the ependymal cell layer) to the LV in high-fat diet (HFD)-fed and leanmice (t(11) =
4.48, p = 0.0009).
(C) Representative images showing Plin2+ cells co-localizing withmarkers of microglia (Iba1; top left panel) and astrocytes (vimentin [Vim]; top right panel), but not
with neuronal markers (NeuN; bottom panel, scale bars, 20 mm).
(D) Pie chart shows cell-type composition of Plin2+ cells, determined after immunostaining for Plin2 and different cell-type markers, as shown in (C).
(E) Periventricular Plin2+ glial cells show increased numbers of the senescencemarker, telomere-associated foci (TAF). Quantification of themean number of TAF
per cell in non-neuronal (NeuNneg) Plin+ and Plin cells (t(10) = 2.475, p = 0.0328).
(F) Representative images show the LV of chow (top panel) and HFD AP20187-treated mice stained with Plin2, exhibiting reduced lipid droplets. Scale bars,
200 mm/50 mm (for magn.)
(G) Quantification of cells containing lipid droplets (Plin2+) in the periventricular area of lean HF INK-ATTAC mice with or without AP20187 treatment (t(11) = 4.48,
p = 0.0009; t(9.362) = 3.28, p = 0.0091).
(legend continued on next page)
Cell Metabolism 29, 1–17, April 2, 2019 9
Please cite this article in press as: Ogrodnik et al., Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis, Cell Metabolism
(2018), https://doi.org/10.1016/j.cmet.2018.12.008
Please cite this article in press as: Ogrodnik et al., Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis, Cell Metabolism
(2018), https://doi.org/10.1016/j.cmet.2018.12.008Impaired Neurogenesis in HFD Animals Is Rescued by
Clearance of Senescent Cells
Ectopic buildup of lipid droplets in AD brains has been shown to
induce dysfunction of neural stem cells residing within the sub-
ventricular zone (SVZ), suppress adult neurogenesis, and cause
cognitive impairment (Hamilton et al., 2015).
In HFD mice, we observed that Plin2+ senescent glial cells are
frequently found in close proximity to cells expressing double-
cortin (Dcx), a marker of neuronal precursor cells and immature
neurons (Figure S7A). Thus, we hypothesized that the presence
of ALISE glial cells could impair adult neurogenesis in the SVZ.
To test this hypothesis, we treated lean and obese INK-ATTAC
mice with or without AP, as previously described. Following or-
gan harvesting, we obtained single-cell suspensions from one
brain hemisphere and analyzed them by cytometry by time of
flight (CyTOF), which allows for mapping and discriminating
between different brain cells including astrocytes, oligodendro-
cytes, microglia, neurons, ependymal cells, pericytes, and
endothelial cells. We reserved the second brain hemisphere for
histological analyses (Figures 7A and 7B).
We found that the brains of HFD-fed mice did not exhibit
significant changes in the frequencies of oligodendrocytes
(CNPase+ or OSP+), microglia (CD11b+, CD45), mature neurons
(NeuN+), or endothelial cells (CD31+ or CD146+) (Figures 7C and
S7B–S7M). However, populations of neuronal precursor cells
(Nestin+), immature neurons (Dcx+), and ependymal cells
(CD133+) were significantly decreased in animals subjected to
HFD feeding (Figures 7C–7G). Clearance of senescent cells by
AP did not alter the frequencies of oligodendrocytes (CNPase+
or OSP+), microglia (CD11b+, CD45), mature neurons
(NeuN+), or endothelial cells (CD146+) (Figures 7C and S7B–
S7M), but it significantly increased neuronal precursor cells,
immature neurons, and ependymal cells (Figures 7C–7G).
CD133+ ependymal cells have been reported to possess proper-
ties of neural stem cells and give rise to Dcx+ neuroblasts and in-
terneurons in the olfactory bulb (Luo et al., 2015). AP treatment
was sufficient to induce partial recovery of obesity-related
stem cell depletion (Figures 7C and 7E) and to replenish
CD133+ and Nestin+ cell abundance (Figures 7F and 7G). Anal-
ysis of cell populations in the brains of db/db mice showed a
similar pattern as those of HFD-fed mice. Markers for immature
neurons (Dcx+), ependymal cells (CD133+), and neuronal precur-
sor cells (Nestin+) were all significantly up-regulated after seno-
lytic treatment with D+Q (Figures S7N–S7P).
We validated these findings by performing immunostaining for
Dcx (Figures 7H and 7I) in the olfactory bulb and EdU-pulse la-
beling (Figures S7S and S7T) in the SVZ of HFD animals. Analysis(H) Quantification of frequencies of NeuNneg, TAF-positive cells in the periventri
p = 0.0107; t(13) = 2.693, p = 0.0184).
(I) Representative images showing double staining for CXCL1 (RNA-ISH in red) an
indicate CXCL1 and Plin2 double positive cells (scale bars, 50 mm/10 mm for mag.
CXCL1, whereas white-bordered cells are not double positive.
(J and K) Quantification of cells positive for (J) Cxcl1 (t(10) = 8.017, p < 0.0001) an
display significantly higher expression levels of the SASP factors, Il-6 and Cxcl1,
(L andM) Buildup of fat in periventricular brain region as assessed by Plin2 staining
(L) percentage of distance traveled in the central zone (percentage of central zo
(entries) in OF testing (r = 0.6976, p = 0.0001).
Data are from n = 5–8 mice per group for (B), n = 6 mice per group for (E), (J), an
and (M). Mean ± SEM plotted. *p% 0.05 and **p% 0.001.
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in the CyTOF experiment) showed a positive correlation between
the area occupied by Dcx+ cells in the granular cell layer of the
olfactory bulb and the frequency of Dcx+ cells detected by
CyTOF (Figure 7J). Quantification of Dcx+ cells (Figures S7U
and S7V) and EdU+ cells (Figure S7W) in the sub-granular zone
(SGZ) of the hippocampus did not show any effect of AP treat-
ment (data not shown), implying that adult neurogenesis in the
SVZ, but not in the SGZ, is affected by the presence of senescent
cells. Interestingly, clearance of senescent cells led to a signifi-
cant increase in the population of astrocytes (Figures S7G–S7I)
in obese animals, whereas no differences between lean and
obese animals were detected. This finding was further confirmed
by immunostaining for Gfap (Figures S7Q and S7R) and may be
related to increased brain plasticity supporting neurogenesis
(Choi et al., 2016). Finally, we found that the frequencies of
Plin2+ glia negatively correlated with the markers of ependymal
cells and markers of adult neurogenesis, Nestin+ (Figure 7K)
and Dcx+ (Figure 7L). Similarly, individual differences in the dis-
tance traveled in the central area were positively correlated
with the frequencies of Dcx+ and Nestin+ cells (Figures 7M
and 7N).
In summary, our data indicate that senescent cells play a
causal role in the impaired neurogenesis induced by obesity.
Targeting senescent cells in obese mice alleviates obesity-
related anxiety-like behavior as a result of the clearance
of periventricular fat accumulation and restoration of adult
neurogenesis.
DISCUSSION
Obesity is a complex disorder and a major risk factor for
many diseases and health problems, including heart disease,
diabetes, stroke, high blood pressure, cancer, osteoarthritis,
and cognitive impairment (Frasca et al., 2017). Additionally,
decreased spatial memory, anxiety, and depression have been
linked to obesity-associated brain inflammation (Guillemot-Le-
gris and Muccioli, 2017). Previous studies have reported that
HFD- and genetically induced obesity in mice results in anxi-
ety-like behavior (Dinel et al., 2011; Heyward et al., 2012; Mizu-
noya et al., 2013). However, similar to other obesity-driven
phenotypes such as physical inactivity (Friend et al., 2017), anx-
iety-like behavior is not simply caused by increased body mass.
Interestingly, loss of body weight alone does not always corre-
spond to improvements in mental health, e.g., after bariatric sur-
gery (Canetti et al., 2016; Cunningham et al., 2012; Fisher et al.,
2017; Kouidrat et al., 2017; Matini et al., 2014). Thus, thecular region of lean/HFD and vehicle- or AP20187-treated mice (t(10) = 3.128,
d Plin2 (green) in the periventricular area of HF INK-ATTAC mice. White arrows
). Cells magnified in panel 4 encircled in red show positive staining for Plin2 and
d (K) Il-6 (t(10) = 8.298, p < 0.0001) stained by RNA-ISH indicate that Plin
+ cells
than Plin cells.
significantly correlates with parameters associated with anxiety-like behavior:
ne) (r = 0.6475, p = 0.0005) and (M) number of entries into the central zone
d (K), n = 4–8 mice per group for (G) and (H), and n = 25 mice per group for (L)
Figure 6. ALISE Phenotype Drives CCF Accumulation and the SASP
Similar to glia in the brains of obese mice, mouse adult fibroblasts (MAFs) show an accumulation of lipids in senescence (ALISE) phenotype.
(A–F) Depletion of lipids from culture media reduces area of lipid droplets inMAFs. (A) The ALISE phenotype inMAFs is characterized by an increased area of lipid
droplets surrounded by Plin2 vesicles (scale bars, 20 mm). (B) Quantification of Nile Red-positive staining in non-senescent young (you) and senescent (sen) MAFs
(p < 0.0001, p = 0.0004). (C and D) Suppression of the ALISE phenotype reduces frequencies of cytoplasmic chromatin fragments (CCF) in senescent fibroblasts
(p < 0.0001, p = 0.0006) (scale bars, 10 mm), but (E) and (F) does not affect number of 53BP1 DNA damage foci (p = 0.0973) (scale bars, 10 mm).
(G–K) Senescent fibroblasts show increased secretion of SASP components including Il-6, KC (Cxcl1), and Ip-10 (Cxcl10) that is alleviated upon suppression of
the ALISE phenotype. (G) Heatmap shows fold change in secretion of SASP components in cell culture media over a 72-hr time period when compared to non-
senescent fibroblasts cultured with lipid-containing media. Each square represents a separate biological replicate, i.e., MAFs isolated from a different mouse
donor. Concentration of SASP components in culture media with and without lipids (ALISE phenotype suppression) for (H) Il-6 (p = 0.0003, p < 0.0001), (I) Ip-10
(Cxcl10) (p = 0.0002, p = 0.0008), (J) Vegf (p = 0.6407, p = 0.003), and (K) Kc (Cxcl1) (p = 0.0114, p = 0.0075).
(L) Images show accumulation of lipid droplets in senescent but not non-senescent GFAP-positive astrocytes (scale bars, 20 mm).
(M–O) Characterization of senescence in astrocytes. Senescent astrocytes show (M) the ALISE phenotype measured using Nile Red staining (t(2.034) = 11.32,
p = 0.0073), (N) increased frequencies of telomere dysfunction measured as the frequency of cells with 1 or more telomere associated DNA damage focus (TAF)
(t(4) = 12.45, p = 0.0002), and (O) increased frequencies of CCF (t(2) = 7.551, p = 0.0171). Senescence was induced by X-ray irradiation (10Gy) and established
within 14–21 days post-irradiation.
Data are from n = 3–6 mice per group. Mean ± SEM plotted. *p% 0.05 and **p% 0.001.
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yet fully understood.
HFD induces senescence in multiple organs, predominantly in
perigonadal adipose tissue (Schafer et al., 2016; Tchkonia et al.,
2010; Xu et al., 2015) but also in other organs including the liver
(Ogrodnik et al., 2017). Until now, the role of HFD in the induction
of senescence in the brain is largely understudied. Recently,
several studies have uncovered a role for senescent glial cells
in neurodegenerative diseases such as tau-dependent pathol-
ogy and Parkinson’s disease (Bussian et al., 2018; Chinta
et al., 2018; Musi et al., 2018).
Our data demonstrating a link between obesity, senescence,
and anxiety-like behavior provide critical support for the potential
feasibility of administering senolytics to treat obesity-associated
anxiety-like behavior, provided that clinical trials validate this
approach.
It should be mentioned that our experimental strategy does
not distinguish which senescent cell types are responsible for
inducing anxiety-like behavior. However, we found that senes-
cent, pro-inflammatory glial cells are frequently found in close
proximity to areas in the brain expressing markers of neuronal
precursor cells and immature neurons, which suggests that
they may exert negative effects on stem cells. While senescence
can impact stem cells in a cell-autonomous fashion by affecting
their proliferation and differentiation (Xu et al., 2015), it had been
previously suggested that senescence can impact stem cells
non-autonomously via the SASP (Krtolica et al., 2011; Pricola
et al., 2009). Consistent with this hypothesis, we found that
SASP factors in blood plasma and specifically in the brain
were increased during obesity and significantly reduced
following both the pharmacogenetic and pharmacological clear-
ance of senescent cells. Nonetheless, neither injection of the
major SASP factor Cxcl1 (which increased during obesity) nor in-
hibition of its receptors had an impact on anxiety-like behavior.
Additionally, transplantation of senescent cells, which has
been previously shown to induce systemic effects and result in
long-lasting physical dysfunction in mice, did not have an impact
on anxiety-like behavior. These data suggest that anxiety-like
phenotypes driven by obesity may be a consequence of senes-
cence occurring locally in specific regions of the brain. However,Figure 7. Clearance of Senescent Cells Partially Reverses the Neural P
(A) Each hemisphere of INK-ATTAC lean and high-fat (HF) mouse brains was eithe
brain cells were labeled with metal-conjugated antibodies and processed for cyt
(B and D) Spanning-tree progression analysis of density-normalized events (SPAD
micrographs. Heatmap shows the intensity of the antibody signal, and the size o
(C) CyTOF shows differences in brain cell populations of INK-ATTAC chow- and
(E–G) Frequencies of cells expressing the markers (E) doublecortin (Dcx) (t(13) = 3.
t(9.674) = 3.383, p = 0.0073), and (G) Nestin (t(13) = 4.405, p = 0.0007; t(15) = 2.217
(H) Representative images of Dcx staining in the olfactory bulb of chow- and HFD
show magnified regions (scale bars, 200 mm).
(I and J) (I) Quantitative analysis of the Dcx-positive area of the granular layer in t
U = 1, p = 0.0476) and (J) correlation between area occupied by Dcx+ cells in the g
brain measured by CyTOF (r = 0.616, p = 0.0111).
(K and L) Correlations (linear regression analysis) between frequencies of perive
expressing markers of neurogenesis and ependymal cells (determined by CyTO
(M and N) Correlations (linear regression analysis) between distance traveled in
p = 0.0074) and (N) Dcx (r = 0.5749, p = 0.0011) (determined by CyTOF).
Data are from n = 5–9mice per group for (C)–(G); n = 2–6mice per group for (I); n = 1
*p% 0.05 and **p% 0.001.given the fact that there are as yet no means to eliminate senes-
cent cells from specific regions of the brain, this hypothesis re-
mains highly speculative.
Dysfunction of peripheral (Ambrosi et al., 2017; Cignarelli et al.,
2012; Matsushita and Dzau, 2017) and neural stem cells (Li et al.,
2014) has been linked to obesity and metabolic syndrome and
inflammation and have been postulated to be among the factors
connecting adult neural stem cell dysfunction to obesity (Li et al.,
2014). Nevertheless, the underlyingmechanisms remain unclear.
We previously reported that reducing the abundance of senes-
cent cells that accumulate with aging restores adipose (Xu
et al., 2015) and bone stem cell function (Farr et al., 2017). Simi-
larly, others have reported improvement in hematopoietic and
hair follicle stem cell function (Chang et al., 2016; Yosef et al.,
2016) and neurogenesis in a model of Parkinson’s disease
(Chinta et al., 2018) following various senolytic treatments.
Here, using CyTOF and EdU-pulse labeling, we demonstrate
that clearing senescent cells in obese mice partially restores
the neural stem cell pool.
A link between anxiety-like behavior in mice and neural stem
cell function has been previously established (Drew and Huckle-
berry, 2017; Siopi et al., 2016). Our data suggest that the subven-
tricular zone-olfactory bulb axis is involved in the therapeutic
effects of senescent cell clearance. Functional inactivation of
the main olfactory epithelium was shown to be sufficient to
induce anxiety-like behavior in mice (Glinka et al., 2012). Addi-
tionally, adults with a history of childhood stress ormajor depres-
sive disorders show reduced olfactory bulb volume (Croy et al.,
2013; Negoias et al., 2010).
Although we show that expression of neurogenesis markers is
negatively associated with anxiety-like behavior, we cannot
exclude the possibility that it is anxiety itself that impairs neuro-
genesis. In a recent study, chronic corticosterone administration
was shown to contribute to anxiety and depression and was suf-
ficient to induce olfactory deficits and impair adult neurogenesis
(Siopi et al., 2016).
In our study, we also made the novel observation that senes-
cent glial cells accumulate lipids, a phenotype that also occurs in
senescent fibroblasts and astrocytes cultured in vitro, which we
termed ALISE. Hamilton et al. (2015) have shown that therogenitor Cell Depletion Induced by Obesity
r dissociated into a single-cell suspension or processed for IHC/IF. Dissociated
ometry by time of flight (CyTOF).
E) was performed on brain cell populations identified by markers shown on the
f each spot is determined by the number of cells within this population.
HFD-fed mice, which were treated with vehicle or AP20187.
057, p = 0.0092; t(15) = 2.236, p = 0.041), (F) CD133 (t(6.291) = 3.339, p = 0.0146;
, p = 0.0425) were quantified.
-fed mice treated with vehicle or AP20187 (scale bars, 250 mm). White boxes
he olfactory lobe of lean and obese INK-ATTAC mice (t(6) = 2.707, p = 0.0352;
ranular layer of the olfactory bulb and frequencies of Dcx+ cells from the whole
ntricular glia exhibiting accumulation of lipid droplets and frequencies of cells
F): (K) Nestin (r = 0.5887, p = 0.002) and (L) Dcx (r = 0.5022, p = 0.0105).
the central zone and the frequencies of cells expressing (M) Nestin (r = 0.487,
1mice per group for (J); n = 29mice per group for (K)–(N). Mean ± SEMplotted.
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models of AD and human AD patients. They also reported that
these lipids are derived from the cerebrospinal fluid and that
the presence of lipid droplets is associated with neuronal stem
cell dysfunction in a mouse model of AD (Hamilton et al.,
2015). Our data show that it is the presence of lipid-containing
senescent cells, rather than accumulation of lipids per se, that
contributes to impaired neurogenesis. Our data imply that it is
the elimination of senescent cells, rather than the reduction of
lipid availability, that improves neurogenesis and alleviates
mouse anxiety-like behavior.
Mechanistically, lipid accumulation in senescent cells has
been related to mitochondrial dysfunction and impaired fatty
acid oxidation (Ogrodnik et al., 2017). Recent data have shown
that mitochondrial dysfunction during senescence is a key
effector of cellular senescence, playing a role in the stabilization
of the growth arrest (Passos et al., 2010) and the induction of the
SASP (Correia-Melo et al., 2016). Based on these findings and
our data, we speculate that when lipids are available, senescent
cells cannot effectively metabolize them, which in turn results in
increased genomic instability, release of CCF, and induction of
the SASP.
Despite increasing evidence that anxiety is associated with
decreased quality of life, increased depression, and suicide in
obesity (Wagner et al., 2013), there are currently no mecha-
nism-based treatments available. Here, we show that cellular
senescence provides a potential explanation for increased anx-
iety in obese individuals and that targeting senescent cells holds
promise as a therapeutic strategy.
Limitations of Study
While our study shows that senescent cells have an impact on
anxiety, our experimental strategy was not capable of distin-
guishing which senescent cell types are responsible. Further
studies using animal models where senescent cells can be
cleared in a cell-type specific manner will be able to address
this particular pitfall. Obesity does impact locomotion (obese an-
imals move more slowly and tend to freeze more), which may
induce some artifacts to the analysis of anxiety-like behavior.
Future studies may use non-locomotion-based assays such as
marble burying.
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Antibodies
Lexa 555-azide Life technologies Cat: #A20012
Anti-Nestin mouse monoclonal antibody (for CyTOF) Abcam Cat # ab6142; RRID: AB_305313
Anti-CD133 rat monoclonal antibody (for CyTOF) Biolegend Cat # 141202; RRID: AB_10896423
Anti-Doublecortin mouse monoclonal antibody
(for CyTOF)
Abcam Cat # ab135349; Clone: 2G5
Anti-Perilipin 2 guinea pig polyclonal antibody PROGEN synthetic peptide (N-terminal aa 1-12 of
human adipophilin/PLIN2)
Anti-53BP1 rabbit polyclonal antibody Novus Biologicals Cat # NB100-304; RRID: AB_10003037
Anti-GFAP guinea pig polyclonal antibody (for IHF) Synaptic Systems Cat # 173 004; RRID: AB_10641162
Anti-g-H2A.X rabbit monoclonal antibody Cell Signaling Technology Cat # 9718; RRID: AB_2118009
Anti-Doublecortin rabbit antibody (for IHF) Cell Signaling Technology Cat # 4604; RRID: AB_561007
Anti-Glial Fibrillary Acidic Protein (GFAP) rabbit
antibody (for IHC)
Original Manufacturer: Dako;
Now: Agilent Technologies
Cat # N1506; RRID: AB_10013482
Anti- CD11b (Mac-1) Fluidigm Cat: #3154006B
Anti- CD45 Fluidigm Cat: #3089005B
Anti- CD31 Fluidigm Cat: #3165013B
Anti- CD146 Fluidigm Cat: #3141016B
Anti-Vimentin Abcam Cat:# ab8978
Anti-ACSA-2 Miltenyi Biotec Cat:# 130099138
Anti-GFAP ebioscience Cat:# 14-9892-82
Anti-NeuN abcam Cat:# ab177487
Anti-CNPase abcam Cat:# ab53041
Anti-OSP abcam Cat:# ab53041
Chemicals, Peptides, and Recombinant Proteins
AP20187 MCE MedchemExpress.com Cat: # HY-13992/CS-1953
EdU Life technologies Cat: #E10187
Dasatinib LC Laboratories Cat: # D-3307
Quercetin Sigma Cat: # Q4951
Recombinant CXCL1 Peprotech Cat# 250-11
Reparixin L-lysine salt MedChemExpress Cat: # HY-15252
Critical Commercial Assays
Adult Brain Dissociation Kit Miltenyi Biotec, CA Cat: #130-107-677
Mouse Cytokine Array / Chemokine Array 31-Plex Eve Technologies; Canada MD31
M-MLV Reverse Transcriptase kit Life Technologies Cat# 28025013
CyTOF for conjugating antibodies with metals Fluidigm Cat#:201300
RNA-ISH kit Acdbio Cat: #322350
Deposited Data
CyTOF data Mendeley.com http://dx.doi.org/10.17632/w4gnsvjdf6.2
Experimental Models: Cell Lines
Primary Mouse (ear) Adult Fibroblasts (MAFs) Ogrodnik et al. (2017); Jurk et al.
(2014)
N/A
Primary Mouse Embryonic Astrocytes see Method Details section N/A
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Experimental Models: Organisms/Strains
Mouse: C57BL/6 INK-ATTAC Baker et al. (2011) N/A
Mouse: BKS.Cg-Dock7m Homozygous Leprdb/J
(db/db) and BKS.Cg-Dock7m Heterozygous
Leprdb/J (db/+)
Jackson Laboratories Stock No: 000697
Mouse: C57BL/6 INK-ATTAC db/db and db/+ mice Mayo N/A
Mouse: C57BL/6 (Wt) mice Jackson Laboratories Stock No: 000664
Mouse: C57BL/6 Luc+ mice Jackson Laboratories Stock No: 025854
Mouse: C57BL/6 (Wt) mice (transplantation) Dr. Kirkland lab (Mayo) N/A
Oligonucleotides
Primers for p16 (CDKN2A) Applied Biosystems Cat# 4331182; Assay ID: Mm00494449_m1
Primers for p21 (CDKN1A) Applied Biosystems Cat# 4331182; Assay ID: Mm04205640_g1
Primers for TATA-binding protein (TBP) Applied Biosystems Cat# 4331182; Assay ID: Mm01277042_m1
Telomere-specific TelC-Cy3 peptide nucleic
acid probe
Panagene Cat# F1002
RNA-ISH probes Adcbio Cat: # 407721 (Cxcl1), Cat: # 315891 (IL-6),
Cat: # 400281 (eGFP)
Software and Algorithms
Graphpad Prism 5 and 7 GraphPad Software https://www.graphpad.com/scientific-
software/prism/
SPADE TREE ANALYSIS Cytobank https://www.cytobank.org/
Other
Fetal Bovine Serum (FBS) South America,
Lipid Depleted
Biowest Cat# S181L-500
Nile red Sigma-Aldrich Cat# N3013
Rodent Diet With 60 kcal% Fat Research Diets Cat# D12492
Rodent Chow Diet Lab Diet (Lab Supply, Fort Worth,
TX, US)
Cat# 5053
TaqMan Fast Universal PCR Master Mix Life Technologies Cat# 4352042
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Diana
Jurk (jurk.diana@mayo.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Experimental procedures were approved by the Institutional Animal Care and Use Committee at Mayo Clinic (protocol A26415). INK-
ATTAC+/- transgenic mice were generated and genotyped as previously described (Baker et al., 2011) based on experimental stra-
tegies devised by J.L.K., T.T., J. van Deursen and D. Baker at Mayo Clinic. Briefly, INK-ATTACmice were produced and phenotyped
atMayoClinic. Controls for the INK-ATTAC experiments were INK-ATTAC-null C57BL/6 backgroundmice raised in parallel. C57BL/6
db/db and db/+ mice were purchased from Jackson Laboratories.
Mice were housed 2-5 mice per cage, at 22 +/-0.5C on a 12-12 hour day-night cycle and provided with food and water ad libitum.
Cages and bedding (autoclaved Enrich-o’Cobs (The Andersons Incorporated)) were changed once per week. For high fat diet-
induced obesity studies, mice were randomly assigned to chow- or HFD-fed groups. Mice were fed the high fat diet for 2-4 months
before experiments started. High fat food was purchased from Research Diets (cat no #D12492). 60% of calories in this high fat diet
are from fat. Standard mouse chow diet was obtained from Lab Diet (cat no #5053). In all the experiments littermates of the same sex
were randomly assigned to experimental groups.
INK-ATTAC mice were injected intraperitoneally (i.p.) with AP20187 (10mg/kg) (MCE MedchemExpress; Cat: # HY-13992/CS-
1953) or vehicle (4% ethanol, 10% PEG-400, and 2% Tween-20 in distilled water) for 3 days every 2 weeks for a total of 8-10 weeks.Cell Metabolism 29, 1–17.e1–e8, April 2, 2019 e2
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(Q; 50mg/kg) (Sigma; Cat: # Q4951) or vehicle (60% Phosal, 10% ethanol, and 30% PEG-400) for 5 days every 2 weeks for 8 weeks.
For off target effect measurements db/db andHDF-fedmice (HFD for 2months prior treatment) were injected intraperitoneally (i.p.)
with 10mg/kg AP21087 or vehicle for 3 days every 2 weeks for 8 weeks.
Recombinant CXCL1 (Peprotech, #250-11) or vehicle (PBS) was administered to lean C57BL/6 via i.p. injection (5mg/kg in PBS)
daily for 7 days. Two hours after the last injection mice were tested in open field and elevated plus maze and dissected afterwards.
Reparixin L-lysine salt (MedChemExpress, #HY-15252) or L-Lysine hydrochloride (MedChemExpress, #HY-N0470) dissolved in
H2O was administered to obese C57BL/6 mice (fed for 2 months with HFD) via subcutaneous injection (30 mg/kg) twice per day
for 2 weeks. Two hours after the last injection, mice were tested in open field and elevated plus maze and dissected afterwards.
Tissues frommice sacrificed at the indicated time points were snap-frozen in liquid nitrogen for biochemical studies or fixed in 4%
Paraformaldehyde (PFA) for 24 hours prior to processing and paraffin embedding. Paraffin-embedded tissues were cut at 3mm or
10mm intervals.
Cell Culture
Mouse Adult Fibroblasts (MAF)
MAFwere extracted from 3-5month oldmale C57BL/6mice. Ear clippings were transported and stored (not longer than 1h) in serum-
free DMEM on ice. Punches were washed 3 times with serum-free media, finely cut and incubated for 2–3 h at 37C in DMEM con-
taining 2 mg/ml collagenase A. A single-cell suspension was obtained by repeated pipetting and passing through a 24-G fine needle.
Cells were centrifuged for 10min at 1,000 r.p.m. and cultured in Advanced D-MEM/F-12 (DMEM, Invitrogen) plus 100 IU/ml penicillin/
streptomycin, 2 mM L-glutamine and 10% FBS (Sigma) in 3% O2 and 5% CO2 at 37
C. Each cell strain was derived from a separate
donor mouse and expanded until enough cells are generated for freezing aliquots. MAFs were thawed at least a week before exper-
iments were conducted. For each experiment, MAFs were seeded at the density of 30000 cells per well of a 12well plate on sterilized,
glass, 19mm (diameter) coverslips, allowed to grow for 24h and then fixed in 2%PFA (young cells) or X-ray irradiated with 10Gy using
a PXI X-Rad 225 (RPS Services Ltd) to induce cellular senescence. Mediumwas changed twice aweek. The last medium changewas
performed at day 20 after senescence induction (IR) and cells were fixed in 2% PFA the next day.
For cytokine measurements, media from the last 24h of culture (before cell fixation) were sent to Eve Technologies for SASP
assessment (Mouse Cytokine Array / Chemokine Array 31-Plex (MD31)).
Lipid Deprivation Experiments
Under normal conditions, MAFs were kept in Advanced DMEM/F-12 (DMEM, Invitrogen) supplemented with 10% fetal bovine serum
(FBS) (Sigma), 100 IU/ml penicillin/streptomycin, and 2 mM L-glutamine. In order to reduce content of lipids in tissue culture media,
lipid-deprived FBS (Biowest) was used. Media containing standard FBS (with lipids) was designated ‘‘LIPID’’ and media containing
lipid-deprived FBS was designated as ‘‘NO LIPID’’. Young (non-senescent control) cells were kept for at least 7 days under ‘‘NO
LIPID’’ conditions before they were collected or senescence was induced.
Mouse Neocortical Astrocytes
Astrocytes were extracted from 16-day-old embryo brains of either sex. At the 16th day of pregnancy, mice were sacrificed and
brains of embryos were dissected. Neocortex was isolated and homogenized by pipetting through a fire-polished, FBS-coated Pas-
teur pipette. Bigger pieces of the neocortex were isolated by sedimentation and supernatant was centrifuged to isolate astrocytes.
Astrocyte cultures were seeded at a density of 0.5 3 106 cells/ml on culture dishes that had been coated previously with 15mg/ml
poly-l-ornithine overnight and subsequently washed with H2O and PBS. Astrocytes were maintained in DMEM/F12 medium supple-
mented with 5mM HEPES, 33mM glucose, 13mM sodium bicarbonate, 10% fetal bovine serum, 2mM glutamine 100U/ml penicillin,
and 100mg/ml streptomycin (all from Invitrogen). Cells were cultured at 37C in a humidified atmosphere of 5% CO2 and 3% O2. In-
duction of senescence and assessment of senescence markers and the ALISE phenotype were performed as for MAFs.
METHOD DETAILS
Senescent and Young Cells’ Transplantation
Wild-type C57BL/6 mice were obtained from the National Institute on Aging (NIA) and maintained in a pathogen-free facility at 23–
24C under a 12h light, 12h dark regimen with food and water ad libitum. Cell transplantation was done as previously described (Xu
et al., 2018). Briefly, 18month oldmicewere anesthetized using isoflurane andwere injected intraperitoneally with 150ml PBS through
a 22-G needle containing 106 non-senescent control or senescent mouse preadipocytes or only PBS. Preadipocytes were obtained
from inguinal fat from young luciferase-expressing transgenic C57BL/6 mice from the Jackson Laboratory Harbor, (Bar, ME; stock
no. 025854). Senescence was induced by 10 Gy cesium radiation. Open field testing was carried out 2 and 6 weeks after transplan-
tation and Rotarod performance was tested 2 and 12 weeks after transplantation.
Body Composition
Lean and fat masses of individual mice were determined by quantitative nuclear magnetic resonance using an EchoMRI analyser
(Houston, TX) and expressed as a function of bodyweight. Un-anesthetized animals were placed in a plastic tube that was introducede3 Cell Metabolism 29, 1–17.e1–e8, April 2, 2019
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Open Field Testing
Locomotor activity and anxiety-like behavior of mice were assessed in sound-insulated, rectangular activity chambers (Med Asso-
ciates, St Albans, VT, USA: W3L3D = 27cm327cm320cmwith continually running fans, infrared lasers, and sensors). Beam breaks
were assessed in 2-min bins over 30 min, converted automatically to current mouse location and distance travelled (cm), and re-
corded on a computer withMed-PC software Version 4.0. Before the test, mice were acclimatized to the room for 1-1.5h before being
introduced into the chambers. Mice were habituated for 5 min in the Open Field chamber (without recording) then placed for another
5 min in the home cage. Afterwards, mice were introduced back to the chambers and all mouse movements were recorded for
30 min. Anxiety was quantified by the distance mice travelled in the central 25% of the chamber (zone 1) as a function of the total
distance mice travelled and by frequencies of entries into zone 1.
Elevated Plus Maze
A grey colored elevated plus maze apparatus was used. Two open arms (253 5 cm) and two closed arms (253 5 cm) were attached
at right angles to a central platform (53 5 cm). The apparatus was set 40 cm above the floor. Mice were first acclimatized to the room
for 1-1.5h and then placed individually on the central platform with their back to one of the open arms. Before the test, mice were
habituated for 1 min to the maze, then placed back in the home cage for 5 min. Mice were tested for 5 min, during which they could
freely explore the apparatus. Tracking software (Ethovision) recognizedmouse head, central body point, and the base of the tail. Anx-
iety was quantified by frequency of and time spent during head pokes/dips toward open arms. Higher anxiety is indicated by a lower
frequency of movement into open arms and less time spent there.
Rotarod
The Rotarod performance test evaluates mouse balance and motor coordination. Mice were brought to the test room a day before
testing and habituated overnight. For the baseline tests, mice were first trained on Rotarod (3375-M5; TSE systems) for three consec-
utive days. Mice were placed (having their back turned towards the experimenter) on the rotating rod of 4.0cm diameter. Mice trained
to stay on the rod for 200sec at one constant speed per day, increasing the speed each day from 4rpm, 6rpm, to 8rpm. If a mouse fell
during training, it was put back on the rod. For the test on the fourth day, the Rotarod was started at 4rpm and steadily accelerated to
40rpm over a 5 min interval. The speeds at which mice dropped were recorded in 4 consecutive trials. Two and 12 weeks after base-
line measurements, mice were tested again, habituating overnight prior to the test day. The average was normalized to the baseline
and taken as an indicator of mouse balance and motor coordination.
Stone’s T-Maze
A water-motivated version of the Stone’s T-maze was used to measure murine short-term memory. A straight run (for pre-training)
or Stone’s T-maze were placed into a steel pan filled with water to a depth of approximately 3 cm so that half the height of the
interior walls of the maze were underwater. The ceilings of both the straight run and the maze were covered with clear acrylic to
prevent mice from rearing out of the water. These dimensions created a situation that enables the mice to maintain contact with
the floor while keeping their heads above water. The mice were placed into a start box and were pushed into the maze using a
sliding panel. At the end of the straight run or the maze there was a goal box that contains a ramp to a dry floor, which allows the
mice to escape from the water upon successful completion of the straight run or the maze. On day one, mice underwent straight
run training to establish the concept that moving forward allows them to escape the water by reaching a water-free goal box. Suc-
cessful completion of this phase requires the mice to reach the goal box in 10 seconds or faster in 8 out of 10 trials. Mice that did
not reach this criterion were excluded from further testing. Maze training commenced the following day. Mice had to complete 9
maze acquisition trials in a single day. All mice per group performed one trial before performing the next one. Runs using between
6 and 8 mice resulted in inter-trial intervals (ITI) of approximately 5-12 minutes. During ITI, mice were placed in a holding cage
containing a dry towel that was additionally heated by a red heat lamp. Primary measures of learning and memory were the latency
to reach the goal box and the numbers of errors committed. An error was defined as complete entry of the mouse’s head or the
whole body into an incorrect path. During the acquisition phase, if any mouse failed to reach the goal box within 5 minutes, the trial
was terminated and scored as a failure. Any mouse having 3 failures was removed from further trials. None of the mice was
excluded from this study.
RT-PCR
Total RNA was extracted from white adipose tissue and brain using Trizol (Life Technologies, Carlsbad, CA) and reverse transcribed
to cDNA with an M-MLV Reverse Transcriptase kit (Life Technologies). Real-time PCR was performed in a 7500 Fast Real Time PCR
System (Applied Biosystems, Foster City, CA) using TaqMan Fast Universal PCR Master Mix (Life Technologies) and predesigned
primers and probes from Applied Biosystems (Assay ID: Mm00494449_m1 [CDKN2A]; Mm04205640_g1 [CDKN1A]). Target gene
expression was expressed as 2DDCT by the comparative CT method and normalized to the expression of TATA-binding protein
(TBP) (Assay ID: Mm01277042_m1 [TBP]).Cell Metabolism 29, 1–17.e1–e8, April 2, 2019 e4
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On the day of sacrifice, a small piece of adipose tissue was fixed with 2% PFA and 0.5% glutaraldehyde (Sigma) for 15 minutes
at room temperature before being incubated overnight in SA-b-Gal solution (150mM NaCl (Sigma), 2mM MgCl2 (Sigma), 40mM
Citric Acid (Sigma), 12mM NaPO3 (Sigma), 400mg/ml X-gal (Thermofisher), 2.1mg/ml potassium hexacyanoferrat(II)trihydrate and
1.65mg/ml Potassium hexacyanoferrat(III)trihydrate (Sigma), pH 6.0) at 37C overnight. Fat chunks were washed with PBS three
times and stored in PBS at 4C protected from light. Within 3 days, adipose tissue was stained with Hoechst solution (1:5000;
Thermofisher), lightly squashed between two 1x3 inch glass slides, and imaged using a light microscope. 10-20 random visual fields
were captured at 20x magnification at identical light exposures for all samples. Images were quantified by manual counting of
SA-b-Gal positive cells by a blinded assessor and the data were expressed as percent of total DAPI-positive cells.
Mass Cytometry/CyTOF in Brain
This technique uniquely combines time-of-flight mass spectrometry with metal-labelling technology to enable detection of up to 40
protein targets per cell. A panel of antibodies based on surface markers, transcription factors, and cytokines (see table below) was
designed for brain mass cytometry/cytometry by time of flight (CyTOF). Each antibody was tagged with a rare metal isotope and its
function verified by mass cytometry according to the manufacturer’s manual (Multi Metal labelling Kits, Fluidigm, CA). A CyTOF-2
mass cytometer (Fluidigm, South San Francisco, CA) was used for data acquisition. Acquired data were normalized based on
normalization beads (Ce140, Eu151, Eu153, Ho165, and Lu175). A single brain hemisphere was dissociated into a single-cell suspen-
sion using brain tissue dissociation kits following the manufacture’s instructions. (Adult Brain Dissociation Kit, Miltenyi Biotec, CA).
Collected cells were incubated with metal-conjugated antibodies in cell staining buffer (ProductMaxpar Cell Staining Buffer, Fluid-
igm, CA) and, for testing intracellular proteins including transcription factors and cytokines, fixation and permeabilization was con-
ducted according to the manufacturer’s instructions (Transcription Factor Staining Buffer Set, eBioscience, San Diego, CA). CyTOF
data were analyzed by Cytobank (Santa Clara, CA).Antibodies Used in CyTOF
Name of an Antigen Company Producing Antibody Catalogue Number Metal Isotopes Dilution
CD11b (Mac-1) Fluidigm 3154006B 154Sm 1:200
CD45 Fluidigm 3089005B 89Y 1:400
nestin Abcam ab6142 148Nd 1:100
Dcx Abcam ab135349 173Yb 1:100
vimentin Abcam ab8978 161Dy 1:100
CD133 Biolegend 141202 153Eu 1:100
ACSA-2 Miltenyi Biotec 130099138 142Nd 1:100
Gfap Ebioscience 14-9892-82 172Yb 1:100
CD31 Fluidigm 3165013B 165Ho 1:100
NeuN Abcam ab177487 169Tm 1:50
CD146 Fluidigm 3141016B 141Pr 1:100
CNPase Abcam ab53041 151Eu 1:200
OSP Abcam ab53041 159Tb 1:200Cytokines
MAFs and astrocytes were plated on 19mm (diameter) coverslips and, at the end of experiments, washed briefly with PBS and fixed
for 10 min with 2% paraformaldehyde dissolved in PBS. Cells were permeabilized for 5 min with 0.5% TRITON X-100 diluted in PBS.
Cells were incubated with blocking buffer (5% normal goat serum (S-1000, Vector Laboratories) in PBS) for 60 min at room temper-
ature. Plin2 (PROGEN #GP46, 1:250), 53BP1 (Novus Biologicals, #NB100-304, 1:250), and GFAP (Synaptic Systems, #173 004,
1:1000) antibodies were diluted in blocking buffer and applied overnight at 4C. The next day, cells were washed 3 times with
PBS and incubated for 60 min with secondary Alexa Fluor 647, goat, anti-guinea pig antibody (1:1000) for Plin 2 staining; Alexa Fluor
488, goat, anti-rabbit (1:1000) for 53BP1 staining or Alexa Fluor 647, goat, anti-guinea pig (1:1000) for GFAP staining. For quantifi-
cation of senescencemarkers, coverslips were washed 3 times in PBS, thenmounted in Vectashield, DAPI-containing mountingme-
dia. For assessment of lipid accumulation, cells were washed 3 times with PBS before and after DAPI solution (PARTEC), which was
added for 30min at room temperature. 2ml of Nile red solution (Nile red (SigmaN3013) 150mgml-1 in acetone) were added to 1ml 80%
glycerol (in Milli-Q water) and mixed thoroughly. 20ml of Nile Red/glycerol were directly added to each cell sample and mounted on a
glass microscope slide. Images were taken immediately after mounting using a Leica DM5500 widefield fluorescence microscope
with a 20x objective lens. Area of lipid droplets was quantified using ImageJ (‘‘Analyze particles’’ tool) in >50 cells in R10 images
per biological replicate.e5 Cell Metabolism 29, 1–17.e1–e8, April 2, 2019
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For EdU experiments, HFD and control chow-fed INK-ATTAC mice treated with AP were injected with EdU (Life Technologies;
Cat: #E10187) at a dose 123 mg/kg with the final concentration of 6.15mg/mL, dissolved in sterile PBS (pH 7.4, Fisher Scientific),
2 hours before perfusion. There was a 15min interval between mouse injections to allow for time needed to perfuse each mouse.
The animals were deeply anesthetized with 90mg/kg ketamine and 10mg/kg of xylazine in sterile PBS prior perfusion. Transcar-
diac perfusion with PBS was followed by perfusion with 4% paraformaldehyde in PBS chilled on ice. Brains were harvested and
postfixed overnight in 4% paraformaldehyde in PBS at 4C, washed with PBS, and stored at 4C for vibratome sectioning. Sagittal
brain sections of 50mm were cut on a vibratome and collected sequentially in 6 different plate wells, total of 13 sections, 250mm
apart in each well, representing 1/6 of the brain hemisphere. Sections were stained free-floating in 12-well plates, with all proced-
ures being performed at room temperature at a volume of 500ml in each well. Sections were initially permeabilized in 4% Triton
X-100 (Sigma-Aldrich) in PBS for 1h with 3 subsequent PBS washes. Click reaction was performed for EdU visualization, including
20mM (+)-sodium L-ascorbate (Sigma-Aldrich), 10mM Alexa 555-azide (Life Technologies), and 4mM copper sulfate (Sigma-Al-
drich) in PBS. Sections were incubated with gentle shaking for 15min followed by PBS washing. Brain sections were collected
and placed on gelatinized glass slides. All preparations were mounted with fluorescent mounting medium (DAKO) and
coverslipped.
For assessment of hippocampal neurogenesis, EdU+ cells slides were imaged using a Leica DM5500B fluorescence microscope
with in depth Z stacking. Cells were manually counted in the basal layer of the dentate gyrus in all 13 sections and multiplied by 6 to
obtain an estimate of the number of dividing cells per hemisphere.
For assessment of neurogenesis in the subventricular zone (SVZ), 13 sagittal, 50mm-thick sections were imaged using a Leica
DM5500B fluorescence microscope. In depth Z stacking was used (images were captured as stacks separated by 4mm with a
10x objective). Quantity of positive cells was manually counted in the ventral SVZ using ImageJ and the total number of cells was
normalized to the number of images taken.
Immunostaining and Telomere-Associated Foci (TAF) and Quantification
Paraffin sections were deparaffinized with Histoclear and hydrated in an ethanol gradient followed by water and PBS. Antigen was
retrieved by incubation in 0.01M citrate buffer (pH 6.0) at 95C for 10min. Slides were placed in blocking buffer (1:60 normal goat
serum [S-1000, Vector Laboratories] in 0.1% BSA/PBS) for 60min at room temperature. For TAF staining, slides were additionally
blocked with Avidin/Biotin (Vector Lab, #SP-2001) for 15min each. Primary antibodies used (table below) were diluted in blocking
buffer and applied overnight at 4C. The next day, slides were washed 3 times with PBS and incubated for 30min with secondary
goat, anti-rabbit antibody (1:200; Vector Laboratories #BA-1000) for TAF staining or for 60min with secondary Alexa antibody (table
above). For TAF staining, Fluorescein-Avidin in PBS (1:500; #A-2011, Vector Lab) was applied to each sample for 20min. Slides were
washed 3 times in PBS, which was followed by FISH for TAF detection. Briefly, tissues were crosslinked with 4% paraformaldehyde
for 20min and dehydrated in graded ethanol. Sections were denatured for 10min at 80C in hybridization buffer (70% formamide
(Sigma), 25mM MgCl2, 0.1M Tris (pH 7.2), and 5% blocking reagent [Roche]) containing 2.5mg ml
-1 Cy-3-labelled telomere-specific
(CCCTAA) peptide nucleic acid probe (Panagene), followed by hybridization for 2h at room temperature in the dark. Slides were
washed twice with 70% formamide in 23SSC for 15min, followed by washes in 23SSC and PBS for 10min. Sections were mounted
in Vectashield DAPI-containing mounting media and imaged.
A single, 3mm-thick section permouse was used for TAF staining, while Dcx and Plin2 staining was performed 80mm-apart on three
10mm-thick sections. To quantify periventricular lipid accumulation, 10-30 images in the periventricular region were taken using a
DM5500 widefield fluorescence microscope from Leica with a 10x (for frequency of ALISE-positive periventricular glia) or x40 (for
assessment of ALISE phenotype of ependymal cells) objective lens. Number of Plin2-positive cells (for frequency of ALISE-positive
periventricular glia) or area of Plin2-positive vesicles (for ALISE phenotype of ependymal cells) was assessed using ImageJ software.
For assessment of identity of Plin2+ cells, 10mm-thick sections were stained with a combination of antibodies for Iba1 (secondary
antibody conjugatedwith Alexa Fluor 488), Plin2 (secondary antibody conjugatedwith Alexa Fluor 594), and vimentin (secondary anti-
body conjugated with Alexa Fluor 647) and quantified for frequency of Plin2+ astrocytes (Iba1-, Vim+) and microglia (Iba1+) in the
periventricular region. Separate staining for Plin2 (secondary antibody conjugated with Alexa Fluor 594) and NeuN (secondary anti-
body conjugated with Alexa Fluor 647) were used to determine frequency of Plin2+ neurons in periventricular region. For TAF quan-
tification, in depth Z stackingwas used (imageswere captured as stacks separated by 0.4 mmwith363 objective) followed by ImageJ
analysis.
Serum levels of the cytokines Eotaxin, G-Csf, Tnf-a, Il-6, Ifn-g, Il-1a, Il-1b, Il-17, Il-2, Kc/Cxcl1, Mcp-1, M-Csf, Mig, Mip-1a, and
Mip-1b were determined using a Multiplexing LASER Bead Assay (Mouse Cytokine Array / Chemokine Array 31-Plex (MD31), Eve
Technologies; Canada). Blood was withdrawn from mice by puncturing the sub-mandibular vein on the day of dissection before
an animal was sacrificed. 50mL of serum was shipped to Eve Technologies on dry ice. Due to high variability of data, an unbiased
elimination of outliers was performed using ROUT’s method (Graphpad 7 Prism). The same panel was used to detect SASP-factors
in MAF and 50ml of media were shipped to Eve Technologies on dry ice.Cell Metabolism 29, 1–17.e1–e8, April 2, 2019 e6
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(2018), https://doi.org/10.1016/j.cmet.2018.12.008Immuno- and Nile Red Staining for MAFs and AstrocytesAntibodies Used in Immunostaining
Company Producing Primary
Antibody and Catalogue
Number
Primary Antibody: Origin
and Concentration
Secondary Antibody: Origin and
Concentration
Tertiary Antibody or
Developing System
g-H2A.X Cell Signalling, #9718S Rabbit, 1:250 Anti-rabbit, biotinylated, Goat, 1:200 DSC-fluorescein
(Vector Lab)
Perilipin 2 (Plin2) Synaptic Systems, #GP46 Guinea pig, 1:250 Anti-guinea pig, Alexa 594 or 488,
Goat, 1:1000
Iba1 Abcam, #ab5076 Goat, 1:250 Anti-goat, biotinylated, donkey, 1:1000
S100b Synaptic Systems, #287006 Chicken, 1:1000 Anti-guinea pig, Alexa 594 or 647,
Goat, 1:1000
Vimentin Abcam, #ab24525 Chicken, 1:1000 Anti-guinea pig, Alexa 647, Goat, 1:1000
Dcx (doublecortin) Cell Signalling #4604 Rabbit, 1:250 Anti-rabbit, Alexa 594, Goat, 1:1000
NeuN/FoxO Abcam ab104224 Mouse, 1:500 Anti-mouse, Alexa 647, Goat, 1:1000
Gfap Synaptic systems, #173004 Guinea pig, 1:500 Anti-guinea pig, Alexa 647, Goat, 1:1000
EdU Life technologies #E10187 Alex555-azide, 10mm, #A20012
53BP1 Novus Biologicals,
#NB100-304
Rabbit 1:250 Anti-rabbit, Alexa 488, Goat, 1:1000IHC for GFAP
Tissue distribution of glial fibrillary acidic protein (GFAP) in the brain was assessed by immunohistochemistry using an image analysis
workstation after staining with antibodies. The brain sections were pretreated with 0.3% H2O2 methanol for 1h at room temperature
and with normal goat serum for 1h at room temperature. Each specimen was incubated with the primary antibody overnight at 4C.
The primary antibody used in this study and the dilutions were as follows: rabbit anti-cow glial fibrillary acidic protein (GFAP) [1:800,
DAKO, Denmark]. Immunohistochemistry was performed using the VECTASTAIN ABC System (Vector Laboratories, Burlingame,
CA) with the avidin/biotin peroxidase complex (ABC) method. Negative controls included replacement of the primary antibodies
with normal rabbit serum [1:200, DAKO]. Immunoreactivity to rat positive control specimens of the primary antibodies was deter-
mined before use.
RNA In Situ Hybridization (RNA-ISH)
RNA-ISHwas performed after RNAscope protocol fromAdvanced Cell Diagnostics (ACD). Paraffin sections were deparaffinized with
Histoclear, rehydrated in graded ethanol (EtOH), and H2O2 was applied for 10min at room temperature followed by 2 washes in H2O.
Sections were placed in hot retrieval reagent and heated for 15min. After washes in H2O and 100% EtOH, sections were air dried.
Sections were treated with protease plus for 30min at 40C, washed with H2O, and incubated with target probe (p16) for 2h at 40C.
Afterwards, slides were washed with H2O followed by incubation with AMP1 (30min at 40
C) and next washed with wash buffer (WB)
and AMP2 (15min at 40C),WB andAMP3 (30min at 40C),WB and AMP4 (15min at 40C),WB and AMP5 (30min at RT) andWB, and,
finally, AMP6 (15min at RT). Lastly, an RNAscope 2.5 HD Reagent kit-RED was used for chromogenic labelling. After counterstaining
with haematoxylin, sections were mounted.
For analysis of cytokines (Il-6 and Cxcl1), sections were co-stained with antibodies for Plin2 and S100b. Briefly, following chromo-
genic labelling for cytokines, sections were washed 3 times in TBS for 5min each followed by blocking in 0.1%BSA in PBS for 30min
at RT. Sections were incubated overnight with primary antibodies at 4C. Next, sections were washed 3 times in TBS for 5min each
followed by secondary antibody incubation for 1h at RT. After 3 TBS washes sections were mounted using ProLong Gold mounting
media containing DAPI. Probes used: to detect p16 we used eGFP: 400281, for Il-6: 315891, and for Cxcl1:407721 (all from ADC). For
all RNA-ISH experiments data were analyzed by quantifying the%of positive cells (whichmeans each cell containing at least 1 focus
was counted as positive).
QUANTIFICATION AND STATISTICAL ANALYSIS
Data are presented as mean±SEM for all data. All statistical analyses including testing the normality of data distribution were per-
formed using GraphPad Prism 7.01 and a P value <0.05 was considered as significant. The study was designed to compare changes
in parameters between lean and obese animals and between obese and obese treated animals independently. All data were as-
sessed for normality using D’Agostino & Pearson normality test (for n>7) or Shapiro-Wilk normality test (for n 7Rn>3). For differencese7 Cell Metabolism 29, 1–17.e1–e8, April 2, 2019
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(2018), https://doi.org/10.1016/j.cmet.2018.12.008between 2 groups (planned 2-group comparison) t-test were used, data were further tested for equality of variances using F test. For
non-normally distributed datasets (p<0.05 in D’Agostino & Pearson or Shapiro-Wilk normality tests), the Mann-Whitney U test was
used. For normally distributed datasets, Welch’s t-test (if p<0.05 in F test) or Student’s t-test was used. For 2> group comparisons,
one-way ANOVA with Tukey’s multiple comparison test was used. For datasets split on two independent factors, 2-way ANOVA was
used. Correlations were assessed using Pearson’s (for datasets of normal distribution) or Spearman’s (for datasets of non-normal
distribution) rank correlation test. All details regarding statistical tests used for each comparison are in Table S1.
DATA AND SOFTWARE AVAILABILITY
CyTOF data (selected data, due to space restrictions) have been deposited in Mendeley: http://dx.doi.org/10.17632/w4gnsvjdf6.2.
(Full data set will be provided by Yi Zhu: zhu.yi@mayo.edu).Cell Metabolism 29, 1–17.e1–e8, April 2, 2019 e8
